PATENT CLAIM ANALYSIS

Application Number: 16155612
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-06
Patent Classification: ["514", "629000"]

Abstract:
The use of oral colchicine solutions in combination with other therapeutics, while minimizing toxic drug to drug interactions are described herein. Related compositions are also provided.

Claim (Index 2):
The method of  claim 1 , wherein the P-gp inhibitor is carvedilol phosphate.

Metadata:
- Claim Count in Document: 45.0
- Percentile: 97.0
- Lexical Diversity: 1.11538
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16155571', '15848498', '13973897', '14567005', '13092459']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7964174883949398
- 35 USC 102 Novelty (BERT): 0.5954652937185942
- Combined Prediction Score: 0.7763222689273053
- Mean Citation Score: 443.995968
- Max Citation Score: 693.34393
- Similarity Product: 394.23019205582136

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test